You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國藥(01099.HK)劉勇:未來毛利率上升空間有限
阿思達克 08-30 12:23
國藥控股(01099.HK)公布中期業績,純利36.94億元人民幣,按年升3.1%,毛利率達到8.28%,按年提升0.02個百分點。集團執行董事兼總裁劉勇表示,公司一直有關注毛利率水平,認為帶量採購政策下藥品分銷及醫療器材業務毛利率下降,屬行業趨勢。 他指出,集團經過業務及產品結構調整後,與同行相比毛利率水平保持相對穩定,未出現惡化情況,預期可應對帶量採購的影響,但相信毛利率再大幅回升的空間不大。 劉勇又指,公司在上海和北京擁有較多業務,疫情問題在上半年對分銷業務造成影響,料下半年將有所恢復,明年藥品分銷業務料可重回正常發展。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account